+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Oprelvekin. Genetics Institute



Oprelvekin. Genetics Institute



Current Opinion in Investigational Drugs 2(10): 1395-1400



Genetics Institute has developed and launched oprelvekin (rhIL-11; Neumega), a recombinant form of human IL-11. In November 1997, the FDA cleared oprelvekin for the prevention of severe thrombocytopenia and the reduction of the need for platelet transfusions following myelosuppressive chemotherapy in susceptible patients with non-myeloid malignancies 12703021. The product was launched at the end of 1997 [312556]. By December 1999, phase III trials for Crohn's disease (CD) were underway [363007]. Genetics Institute had commenced a 150-patient phase II trial for mild-to-moderate CD and mucositis and the company planned to file regulatory procedures for the indication of CD in 1999 [271210]. An oral formulation for this indication has been developed. Oprelvekin is also undergoing phase I clinical trials for colitis [396157], phase II clinical trials for rheumatoid arthritis [413835] and clinical trials for psoriasis [299644]. In March 1997, Wyeth-Ayerst became the licensee for Europe, Africa, Latin America and Asia (with the exception of Japan). Genetics Institute holds marketing rights for North America [239273]. In Japan, oprelvekin is being developed by Genetics Institute and Yamanouchi; phase III trials have commenced [295049] and were ongoing in May 2001 [411763]. In April 1996, analysts at Yamaichi estimated launch in 2001 and maximum annual sales of over yen 10 billion [215896]. In January 1998, Morgan Stanley Dean Witter predicted Yamanouchi's share of sales to be yen 1 billion in 2001, rising to yen 2 billion in 2002 [315458]. Sales of oprelvekin were US $34 million for Genetics institute in fiscal 2000 while, in July 2001, Credit Suisse First Boston estimated that this figure will be US $30 million and US $34 million in 2001 and 2002, respectively [416883].

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046870541

Download citation: RISBibTeXText

PMID: 11890354


Related references

"A decision meaning a new foundation...": from the Kaiser Wilhelm Institute for Anthropology, Human Genetics and Eugenics to the Max Planck Institute for Molecular Genetics. Medizinhistorisches Journal 46(1): 24-50, 2011

Experimental mutagenesis in barley and broad bean some results obtained in cooperation between the central institute of genetics and research in cultivated plants gatersleben east germany and the institute of genetics sofia bulgaria. Kulturpflanze 33: 33-40, 1985

BMP 2--Genetics Institute/ Medtronic-Sofamor Danek/Integra. Bone morphogenetic protein 2--Genetics Institute/ Medtronic-Sofamor Danek/Integra, INFUSE Bone Graft, recombinant human bone morphogenetic protein 2--Genetics Institute/Medtronic-Sofamor Danek/Integra, RhBMP 2--Genetics Institute/Medtronic-Sofamor Danek/Integra. Biodrugs 16(5): 376-377, 2002

The microbiological institute of the swiss institute of technology of zurich 4. towards the genetics of methane bacteria. Vierteljahrsschrift der Naturforschenden Gesellschaft in Zuerich 131(2): 131-136, 1986

Activities of the Institute for Tree Breeding and Genetics of the Federal Forestry Research Institute. Allgemeine Forstzeitung 93(2): 45-47, 1982

Experiences from the National Institute of Nursing Research: Summer Genetics Institute 2004. Policy, Politics & Nursing Practice 6(1): 15-16, 2006

The microbiological institute of the swiss institute of technology of zurich switzerland 5 genetics of streptomycetes and yeasts. Vierteljahrsschrift Der Naturforschenden Gesellschaft In Zuerich: 205-212, 1986

Jubilee Scientific Conference of Institute of Molecular Genetics and Radiobiology Department of N. V. Kurchatov Institute of Atomic Energy. Molekulyarnaya Genetika Mikrobiologiya i Virusologiya (4): 36-40, 1999

Leading Genetics Explorer Kenneth Berns to Direct University of Florida Genetics Institute. Journal of Investigative Medicine 51(6): 317-318, 2003

Yeast genetics in the Institute of Molecular Genetics of the Russian Academy of Sciences: Results and prospects. Molekulyarnaya Biologiya 33(1): 48-54, 1999

Division of Genetics, Department of Physiology and Genetics, National Institute of Agricultural Sciences, Hiratsuka, Japan. Chromosome Inform. Serv, Tokyo, 3, 4-5, 1962

Institute of Plant Genetics, Polish Academy of Sciences, Poznan, Research Centre for Genetics at Skierniewice. Genet polon 4: 213-16, 1963

Yeast genetics in the Institute of Molecular Genetics: results and prospects. Molecular Biology 33(1): 43, 1999

Russian contributions to the 1939 Genetics Congress. A. Plant Genetics. (American Documentation Institute, Document No. 1563). Russian contributions to the Genetics Congress. A. Plant Genetics, 1939. Document 1563,, 1939

Experimental mutation research in barley and broad bean: selected results from the collaboration between the Central Institute in Gatersleben and the Genetics Institute in Sofia. Kulturpflanze 33: 33-40, 1985